Literature DB >> 24529698

Filling a gap in cervical cancer screening programmes.

Nicolas Wentzensen1, Mark Schiffman2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24529698      PMCID： PMC4198378          DOI： 10.1016/S1470-2045(14)70073-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  8 in total

Review 1.  Process of care failures in invasive cervical cancer: systematic review and meta-analysis.

Authors:  Andrea R Spence; Patricia Goggin; Eduardo L Franco
Journal:  Prev Med       Date:  2007-06-22       Impact factor: 4.018

2.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers
Journal:  CA Cancer J Clin       Date:  2012-03-14       Impact factor: 508.702

3.  Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.

Authors:  Hormuzd A Katki; Walter K Kinney; Barbara Fetterman; Thomas Lorey; Nancy E Poitras; Li Cheung; Franklin Demuth; Mark Schiffman; Sholom Wacholder; Philip E Castle
Journal:  Lancet Oncol       Date:  2011-06-16       Impact factor: 41.316

4.  HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.

Authors:  Murat Gök; Daniëlle A M Heideman; Folkert J van Kemenade; Johannes Berkhof; Lawrence Rozendaal; Johan W M Spruyt; Feja Voorhorst; Jeroen A M Beliën; Milena Babovic; Peter J F Snijders; Chris J L M Meijer
Journal:  BMJ       Date:  2010-03-11

5.  Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.

Authors:  Nicolas Wentzensen; Chang Sun; Arpita Ghosh; Walter Kinney; Lisa Mirabello; Sholom Wacholder; Ruth Shaber; Brandon LaMere; Megan Clarke; Attila T Lorincz; Philip E Castle; Mark Schiffman; Robert D Burk
Journal:  J Natl Cancer Inst       Date:  2012-10-23       Impact factor: 13.506

Review 6.  Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis.

Authors:  Marc Arbyn; Freija Verdoodt; Peter J F Snijders; Viola M J Verhoef; Eero Suonio; Lena Dillner; Silvia Minozzi; Cristina Bellisario; Rita Banzi; Fang-Hui Zhao; Peter Hillemanns; Ahti Anttila
Journal:  Lancet Oncol       Date:  2014-01-14       Impact factor: 41.316

7.  Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia.

Authors:  Lisa Mirabello; Mark Schiffman; Arpita Ghosh; Ana C Rodriguez; Natasa Vasiljevic; Nicolas Wentzensen; Rolando Herrero; Allan Hildesheim; Sholom Wacholder; Dorota Scibior-Bentkowska; Robert D Burk; Attila T Lorincz
Journal:  Int J Cancer       Date:  2012-08-20       Impact factor: 7.396

8.  Triage of HPV-positive women in cervical cancer screening.

Authors:  Nicolas Wentzensen
Journal:  Lancet Oncol       Date:  2012-12-21       Impact factor: 41.316
  8 in total
  6 in total

1.  [Epidemiology, prevention and early detection of cervical cancer].

Authors:  Nicolas Wentzensen
Journal:  Onkologe (Berl)       Date:  2016-08-04       Impact factor: 0.234

2.  HPV-based cervical cancer screening- facts, fiction, and misperceptions.

Authors:  Nicolas Wentzensen; Marc Arbyn
Journal:  Prev Med       Date:  2017-02-06       Impact factor: 4.018

3.  Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling.

Authors:  Johan A den Boon; Dohun Pyeon; Sophia S Wang; Mark Horswill; Mark Schiffman; Mark Sherman; Rosemary E Zuna; Zhishi Wang; Stephen M Hewitt; Rachel Pearson; Meghan Schott; Lisa Chung; Qiuling He; Paul Lambert; Joan Walker; Michael A Newton; Nicolas Wentzensen; Paul Ahlquist
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

Review 4.  Triage of HPV positive women in cervical cancer screening.

Authors:  Nicolas Wentzensen; Mark Schiffman; Timothy Palmer; Marc Arbyn
Journal:  J Clin Virol       Date:  2015-11-28       Impact factor: 3.168

5.  High Expression of SOD2 Protein Is a Strong Prognostic Factor for Stage IIIB Squamous Cell Cervical Carcinoma.

Authors:  Maria Cecília Ramiro Talarico; Rafaella Almeida Lima Nunes; Gabriela Ávila Fernandes Silva; Larissa Bastos Eloy da Costa; Marcella Regina Cardoso; Sérgio Carlos Barros Esteves; Luis Otávio Zanatta Sarian; Luiz Carlos Zeferino; Lara Termini
Journal:  Antioxidants (Basel)       Date:  2021-05-05

6.  Nuclear receptor corepressor (NCoR) is a positive prognosticator for cervical cancer.

Authors:  Daniel Beilner; Christina Kuhn; Bernd P Kost; Theresa Vilsmaier; Aurelia Vattai; Till Kaltofen; Sven Mahner; Elisa Schmoeckel; Christian Dannecker; Julia Jückstock; Doris Mayr; Udo Jeschke; Helene Hildegard Heidegger
Journal:  Arch Gynecol Obstet       Date:  2021-04-16       Impact factor: 2.344
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.